Evertec (EVTC) Q1 2026 Earnings Transcript

Evertec reported Q1 revenue of $247.9 million, up 8% year over year, with adjusted EBITDA rising 9% to $97 million and adjusted EPS up 3% to $0.90. Management raised 2026 guidance to $1.073 billion-$1.085 billion in revenue and reiterated 39%-40% EBITDA margins, while highlighting Dimensa as neutral to slightly accretive in 2026 and synergies starting in 2027. The company also returned $23.1 million to shareholders in the quarter and ended with $450.3 million of liquidity and 2.15x net debt/adjusted EBITDA.

Analysis

EVTC is transitioning from a payments compounder to a regional platform roll-up, and the market is likely underappreciating how much of the near-term P&L is being de-risked by recurring revenue. The important second-order effect is not the headline growth rate; it is that each acquisition expands the cross-sell surface area while compressing incremental integration risk because the company is repeatedly reusing the same playbook across payments, SaaS, risk, and insurance workflows. That creates a path to higher quality revenue mix and eventually better margin durability than a pure transaction processor.

The biggest overhang is timing mismatch: management is explicitly pushing most synergy capture into 2027+, which means 2026 is still a “pay for the platform” year. That creates room for disappointment if investors model near-term EPS too aggressively, especially with leverage already in the low-mid 2x range and capital allocation still split between M&A, buybacks, and debt paydown. The balance sheet is fine, but the equity story depends on execution staying clean through two simultaneous integrations; any slippage would hit sentiment faster than fundamentals.

The contrarian view is that FX is masking some of the core operating story. Brazil strength and currency tailwinds are helping reported growth, but the cleaner signal is constant-currency acceleration in Latin America and stable margins despite pricing pressure elsewhere. If the real weakens or cross-border volatility normalizes, the market may briefly punish the stock even though the underlying thesis is intact; that is likely a buying opportunity, not a thesis break.

Competitive dynamics look favorable for EVTC and less favorable for point-solution vendors in the region. By bundling payments, banking, risk, and insurance-adjacent software, EVTC can win on switching costs and implementation breadth rather than just price, which should pressure smaller local competitors and reduce the attractiveness of standalone niche assets. The key catalyst set is 2H26: proof that new deals convert, plus evidence that Dimensa starts contributing to revenue synergies ahead of the 2027 cost-synergy window.

Key Decisions for Investors

• Long EVTC on any post-print weakness over the next 1-3 weeks; thesis is that 2026 is a setup year and the market will eventually pay for 2027 synergy optionality. Target 10-15% upside if the multiple rerates on recurring-revenue mix and integration credibility.
• Use EVTC call spreads rather than outright equity if volatility stays elevated: buy 6-12 month upside structures to capture the 2H26 catalyst window while limiting downside from a leverage/integration hiccup.
• Pair trade: long EVTC / short BPOP for 3-6 months. EVTC has better M&A-driven growth and cross-sell optionality, while BPOP is more exposed to Puerto Rico discount pressure and lower incremental strategic flexibility.
• Avoid chasing after any further FX-led rally; wait for a pullback if Brazil currency strength is the main driver of the tape. Reported growth is helpful, but the cleaner entry is when the market stops paying for currency and starts underwriting synergy.
• Monitor MELI as an indirect loser in Latin America payments/risk workflows. If EVTC continues to prove it can regionalize platforms, smaller fintech competitors may face slower enterprise win rates; consider relative shorts in higher-multiple LatAm fintech exposure if EVTC execution keeps improving.